Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers-Reference-Cited by-同舟云学术

Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers

Published:2018-03-14 Issue:6 Volume:93 Page:729-735
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Chantepie Sylvain P.¹^ORCID,Garciaz Sylvain²,Tchernonog Emmanuelle³,Peyrade Frederic⁴,Larcher Marie‐Virginie⁵,Diouf Momar⁶,Fornecker Luc‐Mathieu⁷,Houot Roch⁸,Gastinne Thomas⁹,Soussain Carole¹⁰,Malak Sandra¹⁰,Lemal Richard¹¹,Delette Caroline¹²,Ibrahim Ahmad¹³,Gac Anne‐Claire¹,Reboursière Emilie¹,Vilque Jean‐Pierre¹⁴,Bekadja Mohamed‐Amine¹⁵,Casasnovas Rene‐Olivier¹⁶,Gressin Remy¹⁷,Guidez Stéphanie¹⁸,Coso Diane²,Herbaux Charles¹⁹,Yakoub‐Agha Ibrahim¹⁹,Bouabdallah Krimo²⁰,Durot Eric²¹^ORCID,Damaj Gandhi¹²²

Affiliation:

1. Institut d'Hématologie de Basse‐Normandie, CHUCaen France

2. Department of HematologyInstitut Paoli CalmettesMarseille

3. Department of Clinical HematologyUniversity Hospital MontpellierMontpellier France

4. Hematology DepartmentCentre Antoine LacassagneNice France

5. Hematology, Toulouse University HospitalToulouse France

6. Clinical Research DepartmentAmiens University hospitalAmiensEA4666 France

7. Haematology, University HospitalStrasbourg France

8. Hematology, University hospitalRennes France

9. Department of HematologyNantes University HospitalNantes France

10. Department of HematologyCurie Institute, Hôpital René HugueninSaint‐Cloud France

11. Service d'hématologie clinique adulte et de thérapie cellulaire, CHU ESTAING, EA 7453 CHELTER, Université Clermont Auvergne CIC‐501Clermont‐Ferrand France

12. Oncopole Hopital SudAmiens FRA

13. Makassed General HospitalBeirut LBN

14. Institut d'Hématologie de Basse‐Normandie, Centre François BaclesseCaen France

15. Hematology and Cell TherapyEtablissement Hospitalier Universitaire (EHU) 1st NovemberOran Algeria

16. Hematology, University HospitalDijon France

17. Hematology, CHU GrenobleGrenoble France

18. Oncologie hématologique et thérapie cellulaire, CHU PoitiersPoitiers France

19. Hematology, Hôpital HURIEZ UAM allogreffe de CSH, CHRULille France

20. Haematology, CHU de BordeauxBordeaux France

21. Department of HematologyCentre Hospitalier UniversitaireReims Cedex FRA

22. Microenvironnement Cellulaire et Pathologies, Normandie Univ, UnicaenMILPAT Caen14000 France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25077

Reference31 articles.

1. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

2. High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

3. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.

4. Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

5. High‐dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen‐related toxicity;Besien K;Bone Marrow Transplant.,1995

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Toxicity and Efficacy of Four Different Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Patients With Lymphoma: Impact of Drug Shortages in a Resource-Constrained Country;Transplantation and Cellular Therapy;2024-08

2. BeEAM vs. BEAM: evaluating conditioning regimens for autologous stem cell transplantation in patients with relapsed or refractory DLBCL;Annals of Hematology;2024-05-29

3. BeEAM vs. BEAM: Evaluating Conditioning Regimens for Relapsed or Refractory DLBCL Autologous Stem Cell Transplantation;2024-02-27

4. Preparative Regimens Used in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapies;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

5. BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trial;eClinicalMedicine;2023-12